CHAMPIONS ONCOLOGY, INC.

CSBR is the ticker symbol for CHAMPIONS ONCOLOGY, INC., a publicly traded US company.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Key metrics include a return on equity of -6.5%, a debt-to-equity ratio of 5.62.

The company reports trailing twelve-month revenue of $2.90M and net loss of $279,000.

FINOTAUR aggregates real-time and fundamental data on CSBR to help traders and investors make informed decisions. Track CSBR in your trading journal alongside other positions for a unified view of your portfolio.